99mTc-GSA scintigraphy and modified albumin-bilirubin score can be complementary to ICG for predicting posthepatectomy liver failure.


Journal

BMC surgery
ISSN: 1471-2482
Titre abrégé: BMC Surg
Pays: England
ID NLM: 100968567

Informations de publication

Date de publication:
01 Nov 2024
Historique:
received: 28 02 2024
accepted: 09 10 2024
medline: 1 11 2024
pubmed: 1 11 2024
entrez: 1 11 2024
Statut: epublish

Résumé

Posthepatectomy liver failure (PHLF) remains a severe complication after liver resection. This retrospective study investigated the correlation of three hepatic functional tests and whether 99mTc-galactosyl human serum albumin (99mTc-GSA) scintigraphy and modified albumin-bilirubin (ALBI) score are useful for predicting PHLF. This retrospective cohort study included 413 consecutive patients undergoing hepatectomies between January 2017 and December 2020. To evaluate preoperative hepatic functional reserve, modified ALBI grade, indocyanine green clearance (ICG-R15), and 99mTc-GSA scintigraphy (LHL15) were examined before scheduled hepatectomy. Based on a retrospective chart review, multivariable logistic regression analysis adjusted for confounding factors was performed to confirm that mALBI, ICG-R15, and LHL15 are independent risk factors for PHLF. ICG-R15 and LHL15 were moderately correlated (r =  - 0.61) but this correlation weakened when ICG-R15 was about ≥ 20. Weak correlations were observed between LHL15 and ALBI score (r =  - 0.269) and ALBI score and ICG-R15 (r = 0.339). Of 413 patients, 66 (19%) developed PHLF (20 grade A, 44 grade B, 2 grade C). Multivariable logistic regression analyses, major hepatectomy (P < 0.001), mALBI grade (P = 0.01), ICG-R15 (P < 0.001), and Esophagogastric varices (P = 0.007) were significant independent risk factors for PHLF. Subgroup analysis showed that ICG-R15 < 19, major hepatectomy, and mALBI grade and ICG-R15 ≥ 19, major hepatectomy, LHL15, and Esophagogastric varices were significant independent risk factors for PHLF (P = 0.033, 0.017, 0.02, 0.02, and 0.001, respectively). LHL15, the assessment of Esophagogastric varices, and mALBI grade are complementary to ICG-R15 for predicting PHLF risk.

Sections du résumé

BACKGROUND BACKGROUND
Posthepatectomy liver failure (PHLF) remains a severe complication after liver resection. This retrospective study investigated the correlation of three hepatic functional tests and whether 99mTc-galactosyl human serum albumin (99mTc-GSA) scintigraphy and modified albumin-bilirubin (ALBI) score are useful for predicting PHLF.
METHODS METHODS
This retrospective cohort study included 413 consecutive patients undergoing hepatectomies between January 2017 and December 2020. To evaluate preoperative hepatic functional reserve, modified ALBI grade, indocyanine green clearance (ICG-R15), and 99mTc-GSA scintigraphy (LHL15) were examined before scheduled hepatectomy. Based on a retrospective chart review, multivariable logistic regression analysis adjusted for confounding factors was performed to confirm that mALBI, ICG-R15, and LHL15 are independent risk factors for PHLF.
RESULTS RESULTS
ICG-R15 and LHL15 were moderately correlated (r =  - 0.61) but this correlation weakened when ICG-R15 was about ≥ 20. Weak correlations were observed between LHL15 and ALBI score (r =  - 0.269) and ALBI score and ICG-R15 (r = 0.339). Of 413 patients, 66 (19%) developed PHLF (20 grade A, 44 grade B, 2 grade C). Multivariable logistic regression analyses, major hepatectomy (P < 0.001), mALBI grade (P = 0.01), ICG-R15 (P < 0.001), and Esophagogastric varices (P = 0.007) were significant independent risk factors for PHLF. Subgroup analysis showed that ICG-R15 < 19, major hepatectomy, and mALBI grade and ICG-R15 ≥ 19, major hepatectomy, LHL15, and Esophagogastric varices were significant independent risk factors for PHLF (P = 0.033, 0.017, 0.02, 0.02, and 0.001, respectively).
CONCLUSION CONCLUSIONS
LHL15, the assessment of Esophagogastric varices, and mALBI grade are complementary to ICG-R15 for predicting PHLF risk.

Identifiants

pubmed: 39482649
doi: 10.1186/s12893-024-02624-8
pii: 10.1186/s12893-024-02624-8
doi:

Substances chimiques

Indocyanine Green IX6J1063HV
Technetium Tc 99m Aggregated Albumin 0
technetium Tc 99m DTPA-galactosyl-human serum albumin 0
Bilirubin RFM9X3LJ49
Technetium Tc 99m Pentetate VW78417PU1
Radiopharmaceuticals 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

342

Informations de copyright

© 2024. The Author(s).

Références

Zhong JH, Ke Y, Gong WF, et al. Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma. Ann Surg. 2014;260:329–40. https://doi.org/10.1097/SLA.0000000000000236 .
doi: 10.1097/SLA.0000000000000236 pubmed: 24096763
Pinna AD, Yang T, Mazzaferro V, et al. Liver transplantation and hepatic resection can achieve cure for hepatocellular carcinoma. Ann Surg. 2018;268:868–75. https://doi.org/10.1097/SLA.0000000000002889 .
doi: 10.1097/SLA.0000000000002889 pubmed: 30080736
Margonis GA, Buettner S, Andreatos N, et al. Anatomical resections improve disease-free survival in patients with KRAS-mutated colorectal liver metastases. Ann Surg. 2017;266:641–9. https://doi.org/10.1097/SLA.0000000000002367 .
doi: 10.1097/SLA.0000000000002367 pubmed: 28657938
Abdalla EK, Vauthey J-N, Ellis LM, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg. 2004;239:818–25. https://doi.org/10.1097/01.sla.0000128305.90650.71 . discussion 825–817.
doi: 10.1097/01.sla.0000128305.90650.71 pubmed: 15166961 pmcid: 1356290
Poon RT, Fan ST, Lo CM, et al. Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database. Ann Surg. 2004;240:698–708. https://doi.org/10.1097/01.sla.0000141195.66155.0c . discussion 708–610.
doi: 10.1097/01.sla.0000141195.66155.0c pubmed: 15383797 pmcid: 1356471
Schroeder RA, Marroquin CE, Bute BP, Khuri S, Henderson WG, Kuo PC. Predictive indices of morbidity and mortality after liver resection. Ann Surg. 2006;243:373–9. https://doi.org/10.1097/01.sla.0000201483.95911.08 .
doi: 10.1097/01.sla.0000201483.95911.08 pubmed: 16495703 pmcid: 1448949
Sadot E, Koerkamp BG, Leal JN, et al. Resection margin and survival in 2368 patients undergoing hepatic resection for metastatic colorectal cancer: surgical technique or biologic surrogate? Ann Surg. 2015;262:476–85. https://doi.org/10.1097/SLA.0000000000001427 . discussion 483.
doi: 10.1097/SLA.0000000000001427 pubmed: 26258316
Utsunomiya T, Shimada M, Kudo M, et al. A comparison of the surgical outcomes among patients with HBV-positive, HCV-positive, and non-B non-C hepatocellular carcinoma: a nationwide study of 11,950 patients. Ann Surg. 2015;261:513–20. https://doi.org/10.1097/SLA.0000000000000821 .
doi: 10.1097/SLA.0000000000000821 pubmed: 25072437
Wang C, Zheng G, Zhang W, et al. Enhanced recovery after surgery programs for liver resection: a meta-analysis. J Gastrointest Surg. 2017;21:472–86. https://doi.org/10.1007/s11605-017-3360-y .
doi: 10.1007/s11605-017-3360-y pubmed: 28101720
Okabayashi T, Shima Y, Morita S, et al. Liver function assessment using technetium 99m-galactosyl single-photon emission computed tomography/CT fusion imaging: a prospective trial. J Am Coll Surg. 2017;225:789–97. https://doi.org/10.1016/j.jamcollsurg.2017.08.021 .
doi: 10.1016/j.jamcollsurg.2017.08.021 pubmed: 28912030
Yokoyama Y, Nishio H, Ebata T, Igami T, Sugawara G, Nagino M. Value of indocyanine green clearance of the future liver remnant in predicting outcome after resection for biliary cancer. Br J Surg. 2010;97:1260–8. https://doi.org/10.1002/bjs.7084 .
doi: 10.1002/bjs.7084 pubmed: 20602507
Kato A, Nakamoto Y, Ishimori T, Seo S, Uemoto S, Togashi K. Predictability of 99mTc-galactosyl human serum albumin scintigraphy for posthepatectomy liver failure. AJR Am J Roentgenol. 2018;210:158–65. https://doi.org/10.2214/AJR.17.18411 .
doi: 10.2214/AJR.17.18411 pubmed: 29023153
Zhang Z-Q, Xiong L, Zhou J-J, et al. Ability of the ALBI grade to predict posthepatectomy liver failure and long-term survival after liver resection for different BCLC stages of HCC. World J Surg Oncol. 2018;16:208. https://doi.org/10.1186/s12957-018-1500-9 .
doi: 10.1186/s12957-018-1500-9 pubmed: 30326907 pmcid: 6192221
Imamura H, Sano K, Sugawara Y, Kokudo N, Makuuchi M. Assessment of hepatic reserve for indication of hepatic resection: decision tree incorporating indocyanine green test. J Hepatobiliary Pancreat Surg. 2005;12:16–22. https://doi.org/10.1007/s00534-004-0965-9 .
doi: 10.1007/s00534-004-0965-9 pubmed: 15754094
Lisotti A, Azzaroli F, Buonfiglioli F, et al. Indocyanine green retention test as a noninvasive marker of portal hypertension and esophageal varices in compensated liver cirrhosis. Hepatology. 2014;59:643–50. https://doi.org/10.1002/hep.26700 .
doi: 10.1002/hep.26700 pubmed: 24038116
Ohwada S, Kawate S, Hamada K, et al. Perioperative real-time monitoring of indocyanine green clearance by pulse spectrophotometry predicts remnant liver functional reserve in resection of hepatocellular carcinoma. Br J Surg. 2006;93:339–46. https://doi.org/10.1002/bjs.5258 .
doi: 10.1002/bjs.5258 pubmed: 16498606
de Graaf W, Häusler S, Heger M, et al. Transporters involved in the hepatic uptake of (99m)Tc-mebrofenin and indocyanine green. J Hepatol. 2011;54:738–45. https://doi.org/10.1016/j.jhep.2010.07.047 .
doi: 10.1016/j.jhep.2010.07.047 pubmed: 21163547
Cui Y, Ko’nig J, Leier I, Buchholz U, Keppler D. Hepatic uptake of bilirubin and its conjugates by the human organic anion-transporting polypeptide SLC21A6. J Biol Chem. 2000;276:9626–30. https://doi.org/10.1074/jbc.M004968200 .
doi: 10.1074/jbc.M004968200 pubmed: 11134001
Kwon AH, Ha-Kawa SK, Uetsuji S, Inoue T, Matsui Y, Kamiyama Y. Preoperative determination of the surgical procedure for hepatectomy using technetium-99m-galactosyl human serum albumin (99mTc-GSA) liver scintigraphy. Hepatology. 1997;25:426–9. https://doi.org/10.1002/hep.510250228 .
doi: 10.1002/hep.510250228 pubmed: 9021958
Maeda H, Okabayashi T, Kobayashi M, et al. Hepatectomy for hepatocellular carcinoma with indocyanine green excretory defect: a case report. Hepatogastroenterology. 2007;54:1810–2.
pubmed: 18019723
Sumiyoshi T, Shima Y, Okabayashi T, et al. Liver function assessment using 99mTc-GSA single-photon emission computed tomography (SPECT)/CT fusion imaging in hilar bile duct cancer: a retrospective study. Surgery. 2016;160:118–26. https://doi.org/10.1016/j.surg.2016.02.009 .
doi: 10.1016/j.surg.2016.02.009 pubmed: 27059635
Sumiyoshi T, Okabayashi T, Negoro Y, et al. 99mTc-GSA SPECT/CT fusion imaging for hepatectomy candidates with extremely deteriorated ICG value. Jpn J Radiol. 2018;36:537–43. https://doi.org/10.1007/s11604-018-0753-0 .
doi: 10.1007/s11604-018-0753-0 pubmed: 29948545
Hiraoka A, Kumada T. Clinical role of newly developed ALBI and mALBI grades for treatment of hepatocellular carcinoma. Appl Sci. 2020;10:7178. https://doi.org/10.3390/app10207178 .
doi: 10.3390/app10207178
Nakamura I, Iimuro Y, Hai S, Kondo Y, Hatano E, Fujimoto J. Impaired value of 99m Tc-GSA scintigraphy as an independent risk factor for posthepatectomy liver failure in patients with hepatocellular carcinoma. Eur Surg Res. 2018;59:12–22. https://doi.org/10.1159/000484044 .
doi: 10.1159/000484044 pubmed: 29332090
Hackett NJ, De Oliveira GS, Jain UK, Kim JYS. ASA class is a reliable independent predictor of medical complications and mortality following surgery. Int J Surg. 2015;18:184–90. https://doi.org/10.1016/j.ijsu.2015.04.079 .
doi: 10.1016/j.ijsu.2015.04.079 pubmed: 25937154
Kamath PS, Kim WR. Advanced liver disease study group. The model for end-stage liver disease (MELD). Hepatology. 2007;45:797–805. https://doi.org/10.1002/hep.21563 .
doi: 10.1002/hep.21563 pubmed: 17326206
Imamura H, Seyama Y, Kokudo N, et al. One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg. 2003;138:1198–206. https://doi.org/10.1001/archsurg.138.11.1198 . discussion 1206.
doi: 10.1001/archsurg.138.11.1198 pubmed: 14609867
Kudo M, Kitano M, Sakurai T, Nishida N. General rules for the clinical and pathological study of primary liver cancer, nationwide follow-up survey and clinical practice guidelines: the outstanding achievements of the Liver Cancer Study Group of Japan. Dig Dis. 2015;33:765–70. https://doi.org/10.1159/000439101 .
doi: 10.1159/000439101 pubmed: 26488173
Kato Y, Sugioka A, Kojima M, et al. Initial experience with robotic liver resection: audit of 120 consecutive cases at a single center and comparison with open and laparoscopic approaches. J Hepatobiliary Pancreat Sci. 2023;30:72–90. https://doi.org/10.1002/jhbp.1206 .
doi: 10.1002/jhbp.1206 pubmed: 35737850
Kato Y, Sugioka A, Kojima M, et al. Minimally invasive anatomic liver resection for hepatocellular carcinoma using the extrahepatic Glissonian approach: surgical techniques and comparison of outcomes with the open approach and between the laparoscopic and robotic approaches. Cancers. 2023;15:2219. https://doi.org/10.3390/cancers15082219 .
doi: 10.3390/cancers15082219 pubmed: 37190148 pmcid: 10136500
Kato Y, Sugioka A, Uyama I. Robotic liver resection for hepatocellular carcinoma: A focus on anatomic resection. Hepatoma Res. 2021:10. https://doi.org/10.20517/2394-5079.2020.129 .
Rahbari NN, Garden OJ, Padbury R, et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery. 2011;149:713–24. https://doi.org/10.1016/j.surg.2010.10.001 .
doi: 10.1016/j.surg.2010.10.001 pubmed: 21236455
Dindo D, Demartines N, Clavien P-A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13. https://doi.org/10.1097/01.sla.0000133083.54934.ae .
doi: 10.1097/01.sla.0000133083.54934.ae pubmed: 15273542 pmcid: 1360123
Lei Z, Cheng N, Si A, et al. A novel nomogram for predicting postoperative liver failure after major hepatectomy for hepatocellular carcinoma. Front Oncol. 2022;12: 817895. https://doi.org/10.3389/fonc.2022.817895 .
doi: 10.3389/fonc.2022.817895 pubmed: 35359352 pmcid: 8964030
Søreide JA, Deshpande R. Post hepatectomy liver failure (PHLF) – Recent advances in prevention and clinical management. Eur J Surg Oncol. 2021;47:216–24. https://doi.org/10.1016/j.ejso.2020.09.001 .
doi: 10.1016/j.ejso.2020.09.001 pubmed: 32943278
Guglielmi A, Ruzzenente A, Conci S, Valdegamberi A, Iacono C. How much remnant is enough in liver resection? Dig Surg. 2012;29:6–17. https://doi.org/10.1159/000335713 .
doi: 10.1159/000335713 pubmed: 22441614
Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48:452–8. https://doi.org/10.1038/bmt.2012.244 .
doi: 10.1038/bmt.2012.244 pubmed: 23208313
Hayashi H, Beppu T, Okabe H, et al. Functional assessment versus conventional volumetric assessment in the prediction of operative outcomes after major hepatectomy. Surgery. 2015;157:20–6. https://doi.org/10.1016/j.surg.2014.06.013 .
doi: 10.1016/j.surg.2014.06.013 pubmed: 25482462
Hiraoka A, Michitaka K, Kumada T, et al. Validation and potential of albumin-bilirubin grade and prognostication in a nationwide survey of 46,681 hepatocellular carcinoma patients in Japan: the need for a more detailed evaluation of hepatic function. Liver Cancer. 2017;6:325–36. https://doi.org/10.1159/000479984 .
doi: 10.1159/000479984 pubmed: 29234636 pmcid: 5704689
Aida T, Haruki K, Akaoka M, et al. A novel combined C-reactive protein-albumin ratio and modified albumin-bilirubin score can predict long-term outcomes in patients with hepatocellular carcinoma after hepatic resection. Ann Gastroenterol Surg. 2024;8:143–50. https://doi.org/10.1002/ags3.12727 .
doi: 10.1002/ags3.12727 pubmed: 38250682
Maruyama H, Yokosuka O. Pathophysiology of portal hypertension and esophageal varices. Int J Hepatol. 2012;2012: 895787. https://doi.org/10.1155/2012/895787 .
doi: 10.1155/2012/895787 pubmed: 22666604 pmcid: 3362051
Tomimaru Y, Eguchi H, Gotoh K, et al. Platelet count is more useful for predicting posthepatectomy liver failure at surgery for hepatocellular carcinoma than indocyanine green clearance test. J Surg Oncol. 2016;113:565–9. https://doi.org/10.1002/jso.24166 .
doi: 10.1002/jso.24166 pubmed: 26751258

Auteurs

Satoshi Mii (S)

Department of Surgery, Fujita Health University, 1-98 Dengakugakubo, Kutsukake, Toyoake, Aichi, 470-1192, Japan.

Takeshi Takahara (T)

Department of Surgery, Fujita Health University, 1-98 Dengakugakubo, Kutsukake, Toyoake, Aichi, 470-1192, Japan. takahara731026@yahoo.co.jp.

Susumu Shibasaki (S)

Department of Surgery, Fujita Health University, 1-98 Dengakugakubo, Kutsukake, Toyoake, Aichi, 470-1192, Japan.

Takuma Ishihara (T)

Innovative and Clinical Research Promotion Center, Gifu University Hospital, Gifu, 501-1194, Japan.

Takuya Mizumoto (T)

Department of Surgery, Fujita Health University, 1-98 Dengakugakubo, Kutsukake, Toyoake, Aichi, 470-1192, Japan.

Yuichiro Uchida (Y)

Department of Surgery, Fujita Health University, 1-98 Dengakugakubo, Kutsukake, Toyoake, Aichi, 470-1192, Japan.

Hideaki Iwama (H)

Department of Surgery, Fujita Health University, 1-98 Dengakugakubo, Kutsukake, Toyoake, Aichi, 470-1192, Japan.

Masayuki Kojima (M)

Department of Surgery, Fujita Health University, 1-98 Dengakugakubo, Kutsukake, Toyoake, Aichi, 470-1192, Japan.

Yutaro Kato (Y)

Department of Gastroenterological Surgery, Fujita Health University School of Medicine Bantane Hospital, 3-6-10 Otobashi Nakagawa Ward, Nagoya, Aichi, 454-8509, Japan.

Koichi Suda (K)

Department of Surgery, Fujita Health University, 1-98 Dengakugakubo, Kutsukake, Toyoake, Aichi, 470-1192, Japan.
Collaborative Laboratory for Research and Development in Advanced Surgical Intelligence, Fujita Health University, 1-98 Dengakugakubo, Kutsukake, Toyoake, Aichi, 470-1192, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH